tykhr
sign in
free sign up
Checkmate Pharmaceuticals Inc
Biotechnology
Healthcare
CMPI
21.63 M shares
NASDAQ US
traded
27 May 2022
listed
yes
open
10.49
52 week high
10.50
high
10.50
52 week low
2.02
low
10.49
growth
57.42 %
previous Close
10.48
P/E ratio
market cap
231 M
div yield
0
usd
Mar 2022
qoq
revenue
0.00 %
net incoming
-15.87 M
-18.93 %
eps
-17.74 %
eps surprise
2.67 %
net profit margin
-1586700000.00 %
0.00 %
operating incoming
-15.89 M
-18.96 %
net change in cash
-11.20 M
-297.20 %
cash on hand
39.48 M
-22.10 %
cost of revenue
0.00 %
top